MEDICINE

The additive manufacturing for breast cancer prevention

Marvel Medtech will use XJet’s NanoParticle Jetting™ (NPJ) technology to 3D print a ceramic cryotherapy probe

XJet Ltd., the additive manufacturing (AM) company, announced that it has sold an XJet Carmel 1400 3D Printer to North American based start-up, Marvel Medtech. The company will use XJet’s NanoParticle Jetting™ (NPJ) technology to 3D print a ceramic cryotherapy probe – a key component within a new robotic intervention guidance system from Marvel Medtech, designed to freeze and destroy the most dangerous tiny breast cancer tumors and prevent them from growing.

To be used during MRI scans in clinics across the USA, the new system represents a completely new approach to breast cancer prevention. The Marvel Medtech scanner accessory will be vital for early elimination, removing the need for future expensive and invasive biopsy and any other surgical procedures. This technology breakthrough is expected to save thousands of lives, dramatically improve patient care and realize billions of dollars in healthcare savings.

Through this process, the company is also hopeful that the new procedure will kick-start the body’s anti-cancer immune response to further prevent the recurrence of cancerous tumors.

Filed: Moulding
Become our Sponsor
Companies Area

Our sponsors
Our partners
Institutional partners
Astrelia sviluppa siti internet e applicazioni mobile/desktop anche per iPhone iPad e Android a San Benedetto del Tronto, Roma, Ascoli Piceno, Marche